Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays | Zendy

Jonathan A. Lee | Zendy; Paul Shinn | Zendy; Susan Jaken | Zendy; Sarah E. Oliver | Zendy; Francis S. Willard | Zendy; Steven Heidler | Zendy; Robert B. Peery | Zendy; Jennifer Oler | Zendy; Shaoyou Chu | Zendy; Noel Southall | Zendy; Thomas S. Dexheimer | Zendy; Jeffrey K. Smallwood | Zendy; Ruili Huang | Zendy; Rajarshi Guha | Zendy; Ajit Jadhav | Zendy; Karen L. Cox | Zendy; Christopher P. Austin | Zendy; Anton Simeonov | Zendy; G. Sitta Sittampalam | Zendy; Saba Husain | Zendy; Natalie Franklin | Zendy; David Wild | Zendy; Jeremy J. Yang | Zendy; Jeffrey J. Sutherland | Zendy; Craig J. Thomas | Zendy

Open Access

Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays

Author(s) -

Jonathan A. Lee,

Paul Shinn,

Susan Jaken,

Sarah E. Oliver,

Francis S. Willard,

Steven Heidler,

Robert B. Peery,

Jennifer Oler,

Shaoyou Chu,

Noel Southall,

Thomas S. Dexheimer,

Jeffrey K. Smallwood,

Ruili Huang,

Rajarshi Guha,

Ajit Jadhav,

Karen L. Cox,

Christopher P. Austin,

Anton Simeonov,

G. Sitta Sittampalam,

Saba Husain,

Natalie Franklin,

David Wild,

Jeremy J. Yang,

Jeffrey J. Sutherland,

Craig J. Thomas

Publication year - 2015

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0130796

Subject(s) - pubchem , phenotypic screening , drug discovery , pomalidomide , medicine , pazopanib , computational biology , pharmacology , druggability , bioinformatics , phenotype , biology , oncology , sunitinib , thalidomide , genetics , renal cell carcinoma , multiple myeloma , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research